Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Wilkinson

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Anesthesiology|August 1, 1987
Acute effects of halothane anesthesia on arterial and venous concentrations of propranolol in the dogL Gordon, A J Wood, R P Koshakji, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1978
The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dogJ L Data, A Rane, J Gerkens, et al.
British Journal of Clinical Pharmacology|October 1, 1978
Direct measurement of propranolol bioavailability during accumulation to steady-stateA J Wood, K Carr, R E Vestal, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1977
Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug eliminationG W Hepner, E S Vesell, A Lipton, et al.
British Journal of Clinical Pharmacology|June 20, 2003
Disposition of debrisoquine and nortriptyline in Korean subjects in relation to CYP2D6 genotypes, and comparison with CaucasiansP Dalén, M-L Dahl, H-K Roh, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphismC Wandel, J S Witte, J M Hall, et al.
Clinical Pharmacology and Therapeutics|October 1, 1978
Effects of aging and liver disease on disposition of lorazepamJ W Kraus, P V Desmond, J P Marshall, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activityR B Kim, B Leake, M Cvetkovic, et al.
Molecular Pharmacology|October 1, 1994
Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in JapaneseS M De Morais, G R Wilkinson, J Blaisdell, et al.
British Journal of Clinical Pharmacology|February 1, 1980
Effect of heparin administration on plasma binding of benzodiazepinesP V Desmond, R K Roberts, A J Wood, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Anesthesiology|August 1, 1987
Acute effects of halothane anesthesia on arterial and venous concentrations of propranolol in the dogL Gordon, A J Wood, R P Koshakji, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1978
The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dogJ L Data, A Rane, J Gerkens, et al.
British Journal of Clinical Pharmacology|October 1, 1978
Direct measurement of propranolol bioavailability during accumulation to steady-stateA J Wood, K Carr, R E Vestal, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1977
Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug eliminationG W Hepner, E S Vesell, A Lipton, et al.
British Journal of Clinical Pharmacology|June 20, 2003
Disposition of debrisoquine and nortriptyline in Korean subjects in relation to CYP2D6 genotypes, and comparison with CaucasiansP Dalén, M-L Dahl, H-K Roh, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphismC Wandel, J S Witte, J M Hall, et al.
Clinical Pharmacology and Therapeutics|October 1, 1978
Effects of aging and liver disease on disposition of lorazepamJ W Kraus, P V Desmond, J P Marshall, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activityR B Kim, B Leake, M Cvetkovic, et al.
Molecular Pharmacology|October 1, 1994
Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in JapaneseS M De Morais, G R Wilkinson, J Blaisdell, et al.
British Journal of Clinical Pharmacology|February 1, 1980
Effect of heparin administration on plasma binding of benzodiazepinesP V Desmond, R K Roberts, A J Wood, et al.
Pageof 19